Log in to search using one of your social media accounts:

 

Wearable Activity Monitor May Improve Intermittent Claudication Outcomes Wearable Activity Monitor May Improve Intermittent Claudication Outcomes
Supplementing supervised exercise programs with the use of a wearable activity monitor may boost walking distances and quality of life in patients with intermittent claudication, according to a pilot study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 26, 2017 Category: Consumer Health News Tags: News Source Type: news

Quality of care for peripheral artery disease is low
This study is a “call to action” to identify and implement effective physician-targeted and patient-targeted strategies aimed at improving quality of care. These strategies should take advantage of recent advances in behavior change, including leveraging an individual’s social support network to help them mak e lifestyle changes, and providing physicians with feedback about the quality of care they provide to patients with peripheral artery disease.AUTHORSJoseph Ladapo of UCLA and Jeffrey Berger of New York University.JOURNALThe studyis published online by the Journal of the American College of Cardi...
Source: UCLA Newsroom: Health Sciences - May 1, 2017 Category: Universities & Medical Training Source Type: news

Shockwave Medical launches lithoplasty trial
Shockwave Medical said today it enrolled the 1st patient in the Disrupt PAD III trial of its Lithoplasty system, aiming to explore the system’s effectiveness at treating heavily calcified lesions in the leg compared to traditional angioplasty. The company’s Lithoplasty device is designed to use intermittent lithotripsy pulses to disrupt superficial and deep vascular calcium and an angioplasty balloon to expand blockages at low pressures to restore blood flow. The 334-patient trial will have a primary goal of achieving less than 30% residual stenosis without the need for stenting, and al...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Vascular Shockwave Medical Source Type: news

Claudication: Endovascular Therapy-Exercise Combo Best Bet
(MedPage Today) -- Meta-analysis supports insurance coverage of exercise programs (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 3, 2017 Category: Cardiology Source Type: news

Pseudoclaudication: Is it related to claudication?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - March 7, 2017 Category: Consumer Health News Source Type: news

Vertos Medical wins CMS reimbursement for Mild procedure
Vertos Medical said today it won national coverage for its Mild procedure designed to treat lumbar spinal stenosis from the Centers for Medicare & Medicaid Services. The Mild procedure won coverage through a recently approved study as part of CMS’ Coverage with Evidence Development Program, the Aliso Viejo, Calif.-cased company said. Access to the procedure was granted via a CMS-approved claims-analysis study which will passively collect and analyze real-world data on the procedure. “Patient and physician demand for the Mild procedure has grown a great deal, and I’m excited to hear that my patien...
Source: Mass Device - March 7, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Spinal Vertos Medical Source Type: news

Pluristem closes enrolment for Phase II trial of PLX-PAD cells to treat intermittent claudication
Israeli-based drug development company Pluristem Therapeutics has closed enrolment for its Phase II trial of placental expanded (PLX-PAD) cells to treat intermittent claudication (IC), a peripheral artery disease (PAD). (Source: Drug Development Technology)
Source: Drug Development Technology - January 16, 2017 Category: Pharmaceuticals Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Medtronic escapes Infuse lawsuits involving fugitive Ohio doc Medtronic yesterday escaped hundreds of lawsuits filed over the allegedly off-label use of its controversial bone-growth product, Infuse, by a Cincinnati doctor who ...
Source: Mass Device - September 23, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic touts low CD-TLR rates, strong durability in 3-year In.Pact Admiral DCB study | VIVA 2016 Roundup
Medtronic (NYSE:MDT) this week released data from 2 clinical studies evaluating its In.Pact Admiral drug-coated balloon for treating claudication and restenosis, touting sustained durability at 3-years. Results were presented at the Vascular Interventional Advances 2016 conference in Las Vegas this week. 3-year outcomes from the In.Pact SFA trial showed Medtronic’s balloon had long-term clinical benefit superior to plain balloon angioplasty, reported Dr. Prakash Krishnan of New York’s Mt. Sinai Heart. “The In.Pact Admiral is the only DCB to-date with superior performance...
Source: Mass Device - September 22, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Endoscopic / Arthroscopic C.R. Bard Medtronic Mercator MedSystems Shockwave Medical Source Type: news

Revascularization May Best Medical Therapy for Leg Claudication Revascularization May Best Medical Therapy for Leg Claudication
Patients treated for intermittent leg claudication with revascularization report significantly better outcomes than those receiving medical therapy.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2016 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Study: Revascularization beats medical management for intermittent claudication in PAD
Revascularization through endovascular or surgical interventions may be superior to medical management for peripheral artery disease patients with intermittent claudication, according to a new study from the University of Washington, Seattle. Data from the study was published online in JAMA Surgery. The study reported that patients with intermittent claudication, which presents as pain in the calf or foot while walking, who underwent revascularization procedures showed improved walk function, reported better health-related quality of life and fewer symptoms of claudification at 12 months than those who were treat...
Source: Mass Device - August 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Surgical Vascular JAMA Surgery Journal of the American Medical Assn. (JAMA) Source Type: news

Revascularization Associated with Better Function in Intermittent Leg Claudication (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM In patients with intermittent leg claudication, revascularization may lead to greater gains in function, symptoms, and quality of life than medical therapy. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 17, 2016 Category: Primary Care Source Type: news

New, Natural ED Treatment
There is a new natural therapy for erectile dysfunction. That comes as a big surprise to most patients who suffer from ED — because they’ve been told again and again their only solution is a Big Pharma booster like Viagra, or that they should just accept their condition as a part of aging. Common ED Beliefs ED has become so common, it’s the accepted norm in men of “a certain age.” It now affects 30 million men in America. But it shouldn’t. Age is not the issue. It’s the most natural thing in the world to have sex well into your 70s and 80s. ED Causes Your doctor has probably told ...
Source: Al Sears, MD Natural Remedies - May 26, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Men's Health Source Type: news

3 of My Favorite Natural Sex Boosters
Let’s talk about the “S” word. New research shows that sex can help keep your mind sharp as tack as you grow older — and I’m not surprised. Sex can be a great tool for protecting or improving your health Researchers in the U.K. recently tested more than 6,800 people between the ages of 50 and 89. Those with active sex lives scored an amazing 23% higher on cognitive word tests than those with inactive sex lives.1 That’s because your sex hormones are linked to your brain’s reward center. And reward processing plays a fundamental role in motivation, learning and cognition —...
Source: Al Sears, MD Natural Remedies - April 12, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures Source Type: news

ACR Responds to MEDCAC on Peripheral Arterial Disease Care for Seniors
Reston, VA — The American College of Radiology (ACR) — as a member of a coalition of leading medical societies — provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC). In addition, the coalition called for continued research in how to provide the best care for U.S. seniors with lower extremity PAD. “Identifying quality health care and impacting the treatment of a disease that affects millions of Americans are critical,” said Anne C. Roberts, MD, FACR, ACR vice president and co-author of the multisociety r...
Source: American College of Radiology - April 10, 2016 Category: Radiology Source Type: news

Revascularization Plus Exercise Better Than Exercise AloneRevascularization Plus Exercise Better Than Exercise Alone
Commentary on a study comparing the effectiveness of endovascular revascularization plus exercise with exercise only for intermittent claudication, published in JAMA. Medscape General Surgery (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 23, 2016 Category: Surgery Tags: General Surgery Viewpoint Source Type: news

Rare Mineral That Naturally Raises Testosterone Levels
Here at the Sears Institute for Anti-Aging Medicine, I use a few inexpensive, natural ways to safely and effectively raise my patients’ testosterone levels. I’ve found one of the best solutions is an overlooked micronutrient you’ll never hear about from mainstream medicine. I’m talking about the rare mineral, boron. Boron arrived on our planet billions of years ago via cosmic dust and meteor fragments. On Earth, it exists only in compound form. Pure boron has been found only in meteorites. But this element is utterly essential to your health. In the past, your ancestors got nutritional boron throug...
Source: Al Sears, MD Natural Remedies - February 8, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Nutrition Boron mineral sex testosterone Source Type: news

Revascularization before exercise program improves walking for patients with PAD
Among patients with peripheral artery disease and intermittent claudication (cramping pain in the legs due to poor circulation in the arteries, aggravated by walking), a combination therapy of endovascular revascularization (an invasive procedure to improve blood flow in an artery) followed by supervised exercise resulted in greater improvement in walking distances and health-related quality-of-life measures at one year compared with supervised exercise only, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 8, 2015 Category: Science Source Type: news

Revascularization before exercise program improves walking for patients with PAD
(The JAMA Network Journals) Among patients with peripheral artery disease and intermittent claudication (cramping pain in the legs due to poor circulation in the arteries, aggravated by walking), a combination therapy of endovascular revascularization (an invasive procedure to improve blood flow in an artery) followed by supervised exercise resulted in greater improvement in walking distances and health-related quality-of-life measures at one year compared with supervised exercise only, according to a study in the Nov. 10 issue of JAMA. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2015 Category: Global & Universal Source Type: news

CardioBuzz: BP Drug Claudication Findings Faked
(MedPage Today) -- Lead author admits to fabricating trial participants (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 15, 2015 Category: Cardiology Source Type: news

Study of Ramipril in Intermittent Claudication Retracted (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH A study of ramipril's effect in improving walking times among patients with intermittent claudication has been retracted in JAMA … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 15, 2015 Category: Primary Care Source Type: news

Medtech approvals: FDA releases May 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in May 2015: Summary of PMA Originals & Supplements Approved Originals: 5 Supplements: 51 Summary of PMA Originals Under Review Total Under Review: 55 Total Active: 26 Total On Hold: 29 Summary of PMA Supplements Under Review Total Under Review: 547 Total Active: 379 Total On Hold: 168 Summary of All PMA Submissions Originals: 1 Supplements: 62 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 51 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 109.5 FDA Time: 86...
Source: Mass Device - August 6, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Supervised Exercise Best for Intermittent ClaudicationSupervised Exercise Best for Intermittent Claudication
People with intermittent claudication that causes leg pain, cramping or fatigue while walking are able to walk further after months of supervised exercise therapy, compared to unsupervised exercise, according to a new study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 13, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Supervised exercise best for intermittent claudication
(Reuters) - People with intermittent claudication that causes leg pain, cramping or fatigue while walking are able to walk further after months of supervised exercise therapy, compared to unsupervised exercise, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Nutrients For Your Manhood
I treat adults of all ages at my wellness clinic and, at some point during our consultations, we usually talk about the ‘S’ word. The advice in today’s letter is for men – but if you’re a woman, just imagine you’re listening in so you can share it with the man in your life. First of all, from a wellness point of view, I tell my patients: “You should have sex as often as you can, for as long as you live.” Three to four times a week would be ideal. Age should not be an issue. It’s the most natural thing in the world to have sex well into your 70s and 80s.1 In fact, sex h...
Source: Al Sears, MD Natural Remedies - March 13, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Men's Health Nutrition hormones supplements testosterone Source Type: news

Effect of supervised exercise on physical function and balance in patients with intermittent claudication - Mockford KA, Gohil RA, Mazari F, Khan JA, Vanicek N, Coughlin PA, Chetter IC.
BACKGROUND: The aim of the study was to identify whether a standard supervised exercise programme (SEP) for patients with intermittent claudication improved specific measures of functional performance including balance. METHODS: A prospective obser... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 14, 2014 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Global Intermittent Claudication Clinical Trials Market Review 2014 in...
This report provides elemental information and data relating to the clinical trials on...(PRWeb October 05, 2014)Read the full story at http://www.prweb.com/releases/intermittent-claudication/clinical-trials-review/prweb12222165.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2014 Category: Pharmaceuticals Source Type: news

Pseudoclaudication: Is it related to claudication?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 14, 2014 Category: Consumer Health News Source Type: news

Fear of falling in claudicants and its relationship to physical ability, balance, and quality of life - Lane RA, Mazari F, Mockford KA, Vanicek N, Chetter IC, Coughlin PA.
OBJECTIVES: Intermittent claudication is associated with poor physical function, quality of life (QoL), and balance impairment. Fear of falling (FoF) is a recognized contributing factor to poor physical ability. Any link between claudication and FoF is yet... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - February 3, 2014 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Study may bust myth of 'fat and fit' healthy obesity
Conclusion This meta-analysis provides further evidence about the known risk factors for cardiovascular disease and mortality. What this study adds is the indication that people who are metabolically unhealthy regardless of their weight are at increased risk. However, interestingly, no increase in risk was seen for the category of people who are metabolically healthy though overweight. A strength of this meta-analysis is the large sample size. However, the results should be interpreted with caution as: The studies did not use the same criteria for assessing metabolic status. The studies did not use the same criteri...
Source: NHS News Feed - December 4, 2013 Category: Consumer Health News Tags: Food/diet Lifestyle/exercise Obesity Source Type: news

AHA: Procedure Plus Exercise ERASEs PAD (CME/CE)
DALLAS (MedPage Today) -- The combination of endovascular revascularization and a supervised exercise program for patients with peripheral artery disease reduced claudication pain and increased walking distance, researchers reported. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 20, 2013 Category: Cardiology Source Type: news

EMA recommends restricting cilostazol use for PAD
The Europeans Medicines Agency has recommended restricting the use of cilostazol in patients with intermittent claudication. Use should be avoided in those with cardiac problems or on dual anticoagulants. (Source: theHeart.org)
Source: theHeart.org - March 22, 2013 Category: Cardiology Source Type: news

EMA Recommends Restricting Cilostazol Use for PADEMA Recommends Restricting Cilostazol Use for PAD
The Europeans Medicines Agency has recommended restricting the use of cilostazol in patients with intermittent claudication. Use should be avoided in those with cardiac problems or on dual anticoagulants News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 22, 2013 Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news

European Medicines Agency recommends restricting use of cilostazol-containing medicines
Source: EMA Area: News Following a review of the current evidence, the European Medicines Agency's (EMA) Committee on Medicinal Products for Human Use (CHMP) has recommended that the use of cilostazol in the treatment of intermittent claudication should be restricted with a range of new measures aimed at targeting a patient population in which there are clinical benefits, and at the same time minimising important risks.   The Spanish Agency for Medicines and Health Products (AEMPS) asked the CHMP to carry out a review of cilostazol following a number of reports of serious suspected adverse effects, in particular ...
Source: NeLM - Cardiovascular Medicine - March 22, 2013 Category: Cardiology Source Type: news

ACE inhibitor helps in intermittent claudication
Patients taking ramipril walked for longer without painRelated items from OnMedicaRecurrent stroke more likely at very low BPPolypill could halve cardiovascular events Caution urged over intensive glucose controlDaily aspirin use linked to major bleedingStroke rate higher in HIV patients (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 7, 2013 Category: UK Health Source Type: news

Ramipril Improves Walking For People With PAD
Pain-free walking as well as length of walk both improved greatly in patients with claudication following treatment with the ACE blocker ramipril. The new study, published in JAMA, revealed pain-free walking rose by 60 percent on average and maximum walking time doubled following six months of treatment with the ACE inhibitor. Close to every secondary result also improved with ramipril versus placebo, such as functional areas of health-related quality of life and the ankle-brachial index (ABI) - an impairment scale for peripheral arterial disease (PAD)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 6, 2013 Category: Consumer Health News Tags: Vascular Source Type: news

Ramipril Improves Walking For People With Peripheral Artery Disease
Pain-free walking as well as length of walk both improved greatly in patients with claudication following treatment with the ACE blocker ramipril. The new study, published in JAMA, revealed pain-free walking rose by 60 percent on average and maximum walking time doubled following six months of treatment with the ACE inhibitor. Close to every secondary result also improved with ramipril versus placebo, such as functional areas of health-related quality of life and the ankle-brachial index (ABI) - an impairment scale for peripheral arterial disease (PAD)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 6, 2013 Category: Consumer Health News Tags: Vascular Source Type: news

RCT: Effect of ramipril on walking times and QoL in patients with peripheral artery disease and intermittent claudication:
Source: JAMA Area: News Approximately one-third of patients with peripheral artery disease (PAD) experience intermittent claudication, with consequent loss of quality of life (QoL).   This multicentre randomised, double-blind, placebo-controlled trial evaluated the efficacy of ramipril for improving walking ability, patient-perceived walking performance, and QoL in 212 Australian patients with PAD (mean age 65.5 years).   Patients were randomised to receive ramipril (10mg/day; n = 106) or matching placebo (n = 106) for 24 weeks. Patients were observed for two prespecified primary outcomes, maximum and pa...
Source: NeLM - News - February 6, 2013 Category: Drugs & Pharmacology Source Type: news

Ramipril Substantially Improved Walking Times in PAD TrialRamipril Substantially Improved Walking Times in PAD Trial
After six months, patients with peripheral artery disease and intermittent claudication who were treated with ramipril were able to walk considerably longer pain free and walk much farther on a treadmill compared with their peers who received placebo, in a new study. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

ACE inhibitor for PAD may improve pain-free walking
Among patients with peripheral artery disease and intermittent claudication (pain in the calf that comes and goes, typically felt while walking), 24 weeks of treatment with the angiotensin-converting enzyme (ACE) inhibitor ramipril was associated with improvement in pain-free and maximum walking times and the physical health aspect of quality of life, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 5, 2013 Category: Science Source Type: news

ACE Inhibitor Improves Walking In People with Peripheral Artery Disease
Giving an ACE inhibitor to people with peripheral artery disease (PAD) and intermittent claudication reduces pain and increases walking time, according to a new study published in JAMA. Currently the pharmacologic options for this patient population are few and have limited efficacy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 5, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Ramipril substantially improved walking times in PAD trial
After six months, patients with peripheral artery disease and intermittent claudication who were treated with ramipril were able to walk considerably longer pain free and walk much farther on a treadmill compared with their peers who received placebo, in a new study. The gains were greater than typical improvements associated with the two drugs that are currently approved in the US for PAD. (Source: theHeart.org)
Source: theHeart.org - February 5, 2013 Category: Cardiology Source Type: news

Walking Time in PAD Better with ACE Inhibitor (CME/CE)
(MedPage Today) -- Walking duration and pain-free walking both improved significantly in patients with claudication after treatment with the ACE inhibitor ramipril, a randomized trial showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 5, 2013 Category: Cardiology Source Type: news

Ramipril Improves Walking Times in Patients with Intermittent Claudication
(Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 5, 2013 Category: Primary Care Tags: Medical News Source Type: news